High‐level expression of ARID1A predicts a favourable outcome in triple‐negative breast cancer patients receiving paclitaxel‐based chemotherapy - Lin, Yuan‐Feng; Tseng, Ing‐Jy; Kuo, Chih‐Jung; Lin, Hui‐Yu; Chiu, I‐Jen; Chiu, Hui‐Wen (Journal of cellular and molecular medicine, 2018)
Keywords: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols - pharmacology; ARID1A; Breast cancer; Cell Line, Tumor; Chemotherapy; Disease-Free Survival; DNA-Binding Proteins; Drug Resistance, Neoplasm - genetics; Female; Gene Expression Regulation, Neoplastic - drug effects; Humans; Indoles - pharmacology; Kaplan-Meier Estimate; Middle Aged; Nuclear Proteins - genetics; Original; p38 Mitogen-Activated Protein Kinases - genetics; p38MAPK; Paclitaxel; Paclitaxel - administration & dosage; Paclitaxel - adverse effects; Patients; Transcription; Transcription Factors - genetics; Triple Negative Breast Neoplasms - drug therapy; Triple Negative Breast Neoplasms - genetics; Triple Negative Breast Neoplasms - pathology; triple‐negative breast cancer; paclitaxel; triple-negative breast cancer; ARID1A; chemotherapy; p38MAPK